CoLucid Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

CoLucid Pharmaceuticals Ownership

Who owns CoLucid Pharmaceuticals?

CoLucid Pharmaceuticals is owned by Eli Lilly. It was acquired on January 18, 2017.

CoLucid Pharmaceuticals Business Overview

Where is CoLucid Pharmaceuticals headquartered?

CoLucid Pharmaceuticals is headquartered in Cambridge, Massachusetts.

How many employees does CoLucid Pharmaceuticals have?

CoLucid Pharmaceuticals has 7 employees.

What sector is CoLucid Pharmaceuticals in?

CoLucid Pharmaceuticals is a life science company.

When was CoLucid Pharmaceuticals founded?

CoLucid Pharmaceuticals was founded in 2005.

Life Science M&A Summary in 2017

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.

CoLucid Pharmaceuticals, Inc.

222 Third Street, Suite 1320,
Cambridge, Massachusetts 02142
United States,
(857) 285-6495
www.colucid.com

CoLucid Pharmaceuticals, Inc. is a biopharmaceutical company developing an oral 5-HT1F agonist (lasmiditan) for the acute treatment of migraine. CoLucid Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Cambridge, Massachusetts.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.